Literature DB >> 12673118

Isolation and characterization of fourteen novel putative and nine known target genes of the p53 family.

Xinbin Chen1, Gang Liu, Jianhui Zhu, Jiayuan Jiang, Susan Nozell, Amy Willis.   

Abstract

p53, a transcription factor, exerts its tumor suppressor activity by regulating a diverse array of genes involved in the control of the cell cycle, apoptosis, differentiation, and DNA repair. Previously, we and others have found that p53 contains multiple separate functional domains, each of which has a unique contribution to the activity of p53 in inducing cell cycle arrest and apoptosis, probably via differential regulation of target genes. We and others have also found that the p53 family members, that is, p53, p63, and p73, are all capable of inducing cell cycle arrest and apoptosis and regulate both common and unique target genes. Here, we used Affymetrix GeneChip assay and Northern blot analysis to determine whether some known target genes are regulated by various p53 mutants, which are active in inducing cell cycle arrest, apoptosis, or both, and to identify novel target genes regulated by the p53 family. We found that various p53 functional domains control the induction of a target gene, which may be responsible for the unique activity of a given functional domain in inducing cell cycle arrest or apoptosis. In addition, we identified fourteen potential novel target genes that are differentially regulated by various p53 family members. Therefore, the regulation of a known target gene by a defined p53 mutant can be used to classify the role of the target gene in p53 tumor suppression and the identification of these fourteen potential novel target genes of the p53 family can lead to uncover the signaling pathway to which a p53 family member functions in tumor suppression (p53) and in development (p63 and p73).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673118     DOI: 10.4161/cbt.180

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  7 in total

1.  RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript.

Authors:  Limin Shu; Wensheng Yan; Xinbin Chen
Journal:  Genes Dev       Date:  2006-10-18       Impact factor: 11.361

2.  Genetic Ablation of Rbm38 Promotes Lymphomagenesis in the Context of Mutant p53 by Downregulating PTEN.

Authors:  Jin Zhang; Enshun Xu; Cong Ren; Hee Jung Yang; Yanhong Zhang; Wenqiang Sun; Xiangmudong Kong; Weici Zhang; Mingyi Chen; Eric Huang; Xinbin Chen
Journal:  Cancer Res       Date:  2018-01-12       Impact factor: 12.701

3.  The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.

Authors:  Xiao-Xia Li; Liang Shi; Xu-Jie Zhou; Jing Wu; Tian-Song Xia; Wen-Bin Zhou; Xi Sun; Lei Zhu; Ji-Fu Wei; Qiang Ding
Journal:  J Exp Clin Cancer Res       Date:  2017-04-11

4.  The Rbm38-p63 feedback loop is critical for tumor suppression and longevity.

Authors:  Yuqian Jiang; Enshun Xu; Jin Zhang; Mingyi Chen; Elsa Flores; Xinbin Chen
Journal:  Oncogene       Date:  2018-03-09       Impact factor: 9.867

5.  RNPC1 modulates the RNA-binding activity of, and cooperates with, HuR to regulate p21 mRNA stability.

Authors:  Seong Jun Cho; Jin Zhang; Xinbin Chen
Journal:  Nucleic Acids Res       Date:  2010-01-11       Impact factor: 16.971

6.  The role of D-GADD45 in oxidative, thermal and genotoxic stress resistance.

Authors:  Alexey Moskalev; Ekaterina Plyusnina; Mikhail Shaposhnikov; Lyubov Shilova; Alexey Kazachenok; Alexander Zhavoronkov
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

7.  Selective anticancer agents suppress aging in Drosophila.

Authors:  Anton Danilov; Mikhail Shaposhnikov; Ekaterina Plyusnina; Valeria Kogan; Peter Fedichev; Alexey Moskalev
Journal:  Oncotarget       Date:  2013-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.